Fitness6 months ago
Reduced Risk for Peripheral Neuropathy Tied to Diabetes Med
MONTREAL —Tirzepatide (Mounjaro, Eli Lilly), the dual gastric inhibitory polypeptide–glucagon-like peptide 1 (GIP–GLP-1) receptor agonist that has shown significant benefits in diabetes and obesity, may also...